Delhi High Court grants schools more time to set up fee committees and submit hike proposals. The court refuses to stay the new fee regulation law, seeks response from DoE and LG. Next hearing on March 12.
India's drug regulator proposes a major overhaul, including a ban on OTC antibiotic sales and an R&D push, to tackle antimicrobial resistance causing 267,000 deaths annually. Read the full plan.
Delhi High Court refuses to stay new fee regulation law for private schools but extends deadlines. Committees must be formed by Jan 20. Key details inside.
India's CDSCO now regulates AI-based cancer detection software as Class C medical devices, requiring approval and safety validation. Experts call the move timely for patient safety. #Healthcare #AI #India
India introduces a formal mechanism for drug and medical device firms to settle minor regulatory violations by paying fines, aiming to reduce court burdens and focus on serious health risks. Learn how the new compounding rules work.
India bans Nimesulide for those under 18, citing liver damage risks. This crucial step highlights the need for stricter drug regulation to protect public health. Read more.
Indian firms seek CDSCO nod to sell high-strength 6mg nicotine pouches as NRT, sparking fears of youth initiation and addiction. Experts warn of cardiovascular risks.
India's drug regulator CDSCO refuses to disclose risk-based inspection details under RTI, sparking debate on transparency vs. commercial interests. Experts warn this secrecy endangers public health.
India's drug regulator CDSCO cancels the import licence of hair-loss product QR678 Neo for making false therapeutic claims while registered as a cosmetic. Learn the details and regulatory implications.
The Indian government considers a one-year extension for MSMEs to comply with revised Schedule M GMP norms, aiming to prevent plant closures and safeguard its $50 billion pharma sector. Read more.
With no law to regulate digital services, what does India's regulatory gap mean for competition and your digital rights? Mozilla explains the need for tailored rules.
India's drug regulator CDSCO mandates new labelling rules for solvent makers to prevent toxic chemicals from entering medicines. This follows the tragic deaths of at least 25 children in Madhya Pradesh. Read the full story.
Delhi's Directorate of Education mandates all private schools to set up School Level Fee Regulation Committees by January 10, 2026. This historic move under a new law gives parents a direct say in fee hikes.
The Delhi government has introduced a new fee regulation framework for private schools, aiming to ensure transparency and prevent arbitrary hikes. Learn how this impacts parents and institutions.
Smartwatches evolve from fitness trackers to certified health devices in India. With Apple & Samsung leading, the medical wearable market is projected to hit $4.2 billion by 2033. Read more.
The Indian government is considering data exclusivity for pharma, a move that could delay cheap generic drugs, impact India's global edge, and affect medicine access. Read the full analysis.
Himachal Pradesh reports the highest number of substandard drug samples in India. 49 samples failed quality tests, raising serious concerns about public health and pharmaceutical regulation.
Himachal drug controller directs firms to recall stock after 49 medicine samples fail quality tests. Substandard drugs include medication for fever, heart attacks, and diabetes. Learn which medicines to avoid.
India's drug approval process faces delays due to complex scientific hurdles in translational research. Experts explain the challenges and propose solutions for faster patient access to new treatments.
India plans to replace 5-year medical device licenses with perpetual approvals and standardize lab testing to cut compliance costs and attract investment. Read more.
Lords Mark Industries secures CDSCO licence for Class C AI Hemodialysis Machines, a major step for India's med-tech self-reliance. Read how this innovation impacts renal care.
Himachal Pradesh's pharmaceutical hub is in turmoil as 38 firms lose WHO-GMP certification, raising serious quality concerns. Discover the causes and impact.
India mandates QR codes in all pharmacies for instant reporting of medicine side effects. This move aims to transform pharmacovigilance and make drug safety a public responsibility. Scan and report!
Bombay High Court directs a CDSCO expert committee to review Datar Cancer Genetics' plea for human trials of its Per-C-Vax cancer immunotherapy. The panel must submit its report within three months. Read the full details.
India's drug regulator CDSCO refuses to waive local trials for lenacapavir, blocking access to revolutionary HIV prevention for 25 lakh Indians. Learn why this happens despite drug being manufactured in India.
Supreme Court proposes Aadhaar-based age verification for online content and autonomous regulatory body. Hearing cases involving YouTubers over obscenity allegations.
Digital gold companies plan to approach the government for self-regulation approval if Sebi refuses to regulate the sector. Industry seeks transparency amid investor concerns.
World Bank-IMF report reveals critical regulatory gaps in India's financial sector, highlighting limited RBI powers and differential treatment of public vs private institutions.
Exclusive insights from IT Secretary S Krishnan reveal India's strategic approach to Artificial Intelligence - fostering innovation first, regulating when necessary. Discover how India plans to become a global AI powerhouse.
Exclusive: Polygon and Anq partner to create India's first government securities-backed stablecoin model, marking a major leap in digital finance innovation.